Stock LIFE ATYR PHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions aTyr Pharma, Inc.

Equities

LIFE

US0021202025

Delayed Nasdaq
Other stock markets
 16:27:40 02/05/2024 BST 		5-day change 1st Jan Change
1.59 USD 0.00% Intraday chart for aTyr Pharma, Inc. -0.31% +12.77%
03-15 RBC Cuts Price Target on aTyr Pharma to $16 From $19, Keeps Outperform Rating, Speculative Risk Qualifier MT
03-14 Transcript : ATyr Pharma, Inc., Q4 2023 Earnings Call, Mar 14, 2024

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. LIFE Stock
  4. Revisions aTyr Pharma, Inc.